Being one of the world’s oldest crops with significant economic and medicinal importance, Cannabis Sativa L. (cannabis) has attracted an enormous amount of attention and become one of the most popularly cultivated plants worldwide (Gao et al., 2020). The content of Δ9‐tetrahydrocannabinol (THC) determines the legal status of the cannabis varieties. Uncontrolled varieties called hemp are defined as those that have 0.3% or less THC, while marijuana is defined as varieties with higher than 3% (4%‐35%).
Cannabis sativa L. (cannabis) is one of the earliest domesticated crops cultivated for medicinal, food, industrial, and recreational use throughout the world. A growing number of jurisdictions have lifted the prohibition on medical and recreational cannabis with legislation that allows researchers to conduct important and urgently needed research, such as understanding the molecular basis of agronomically important traits. However, a dearth of suitable molecular genetic techniques for the analysis of cannabis species has hampered the elucidation of gene function. Here, we developed a robust protoplast transient transformation system by optimizing conditions of protoplast isolation and polyethylene glycol–mediated transformation using cannabis cotyledons. A protoplast isolation yield of up to 1.15 × 107 cells per gram of fresh material and 98.5% viability and a transformation efficiency of 75.4% were achieved. This optimized protocol for protoplast isolation and transformation was successfully applied to eight representative cannabis varieties, which highlight the versatility and robustness of this technique. Using this protocol, the nuclear localization of a basic helix–loop–helix transcription factor (CsMYC2) was visualized, and the transcriptional activity of CsMYC2 was assessed. These results demonstrate the effectiveness of our cannabis protoplast isolation and transient transformation method that should serve as a powerful molecular research tool in a wide range of molecular studies.
Diabetes is a chronic disease, and its complexity and its various complications complicate studies in diabetes management. Aging is one of the main risk factors for diabetes, and elderly are a high‐risk group for developing the disease. In recent years, increasing evidence has revealed the underlying molecular basis for aging diabetes and its connection to related signal pathways. Several key pathways in the aging process can affect insulin secretion and induce diabetes. In this review, we propose a possible connection between diabetes and aging in terms of development timeline and molecular pathology to better understand this interaction between two diseases, especially aging diabetes. Additionally, cell and animal models associated with diabetes are summarized, as well as a summary of models currently being used to study aging diabetes, and their strengths and limitations are also presented. The explanation of these types of models would help us to better understand the relationship between type 2 diabetes and aging and provide a basis for subsequent research on disease mechanisms and/or drug development.